Covid-19: AstraZeneca vaccine prevents 79% of symptomatic disease and 100% of severe disease, US study finds
Interim analysis of a phase III trial has found that the vaccine produced by Oxford University and AstraZeneca was 79% effective at preventing symptomatic covid-19 and 100% effective at preventing…
